Management of Chronic Suppurative Otitis Media with Homoeopathy.

Efficacy of Individualized Homoeopathy in Management of Chronic Suppurative Otitis Media: A Single-blind, Randomized, Plcebo-Controlled Trial - NIL

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/063382

Enrollment

140

Registered

2024-02-29

Start date

Unknown

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H661- Chronic tubotympanic suppurative otitis media Health Condition 2: H661- Chronic tubotympanic suppurative otitis media

Interventions

Intervention1: Homoeopathic medicines: Individualized Homoeopathic medicines should be prescribed on basis of totality 4 globules of 30 sizes BD or TDS should be given orally as per the susceptibility

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of tubotympanic type chronic suppurative otitis media of more than 2weeks Age group from 1 to 45 years Both sexes Subjects who have given the written informed consent

Exclusion criteria

Exclusion criteria: chronic suppurative otitis media of atticoantral type Patient with history of noise exposure Patient with history of ear surgery Patient not willing to be part of the study Patients with uncontrolled chronic illness

Design outcomes

Primary

Measure	Time frame
â?¢To evaluate the VAS for ear discharge, pain, and deafness To evaluate changes by clinical and otoscopy examination. To assess the hearing level using audiometry test To evaluate the quality of life using chronic otitis media outcome test-15(COMOT -15) questionnaire To assess the recurrence of CSOM during treatment Timepoint: â?¢To assess and compare the symptomatic improvement in ear discharge, pain and deafness using VAS, will be assessed at baseline and every month. â?¢ Otoscopy and audiometry will be done at baseline, 3rd, 6th, 9th and 12th month. â?¢COMOT-15 Questionnaires will be assess at baseline and every month.	—

Measure

Time frame

â?¢To evaluate the VAS for ear discharge, pain, and deafness To evaluate changes by clinical and otoscopy examination. To assess the hearing level using audiometry test To evaluate the quality of life using chronic otitis media outcome test-15(COMOT -15) questionnaire To assess the recurrence of CSOM during treatment Timepoint: â?¢To assess and compare the symptomatic improvement in ear discharge, pain and deafness using VAS, will be assessed at baseline and every month. â?¢ Otoscopy and audiometry will be done at baseline, 3rd, 6th, 9th and 12th month. â?¢COMOT-15 Questionnaires will be assess at baseline and every month.

—

Secondary

Measure	Time frame
1.To compare and assess the clinical improvement using otoscopy and physical examination from baseline, 3rd, 6th, 9th and 12th month ï?· To assess hearing impairment using audiometry(pure tone) test at baseline, 3rd, 6th, 9th and 12 th month ï?· To assess and compare the change in quality of life of CSOM using COMOT-15 questionnaire scores at baseline and every month. ï?· To assess the recurrence of CSOM during treatmentTimepoint: 1. Otoscopy and audiometry (PTA) test -Baseline, 3rd, 6th, 9th and 12th month 2.COMOT-15 questionnaire-Baseline and every month	—

Measure

Time frame

1.To compare and assess the clinical improvement using otoscopy and physical examination from baseline, 3rd, 6th, 9th and 12th month ï?· To assess hearing impairment using audiometry(pure tone) test at baseline, 3rd, 6th, 9th and 12 th month ï?· To assess and compare the change in quality of life of CSOM using COMOT-15 questionnaire scores at baseline and every month. ï?· To assess the recurrence of CSOM during treatmentTimepoint: 1. Otoscopy and audiometry (PTA) test -Baseline, 3rd, 6th, 9th and 12th month 2.COMOT-15 questionnaire-Baseline and every month

—

Countries

India

Contacts

Public ContactDr Punam Kumari

Dr D P Rastogi Central Research Institute of Homoeopathy

drpunamk@gmail.com9910450787

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026